National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant fowlpox-TRICOM vaccine
A cancer vaccine comprised of a recombinant fowlpox virus vector encoding TRICOM. TRICOM is comprised of three co-stimulatory molecule transgenes (B7-1, ICAM-1 and LFA-3) that may enhance antigen presentation and activate cytotoxic T-cells. Fowlpox virus is an attractive vector because its genome is easy to manipulate and it is replication incompetent in mammalian cells. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:rF-TRICOM (B7.1.iCAM1-LFA3-Fowlpox)



Previous:recombinant flt3 ligand, recombinant fowlpox GM-CSF vaccine adjuvant, recombinant fowlpox-B7.1 vaccine, recombinant fowlpox-CEA(6D)/TRICOM vaccine, recombinant fowlpox-prostate apecific antigen vaccine
Next:recombinant fowlpox-tyrosinase vaccine, recombinant human 6Ckine, recombinant human chorionic gonadotropin, recombinant human EGF-rP64K/Montanide ISA 51 vaccine, recombinant human endostatin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov